Platelet‐activating factor detection, metabolism, and inhibitors in the ethanologenic bacterium Zymomonas mobilis

Platelet-activating factor (PAF) is a signaling phospholipid with a significant physiological role in multicellular and unicellular organisms, including fermentative organisms such as yeast. Zymomonas mobilis is an ethanologenic α-proteobacterium currently studied for bioethanol production. In order to examine the presence of PAF and/or PAF inhibitors in Z. mobilis, a new one-step high performance liquid chromatography (HPLC) separation procedure of total lipids was performed, using a C8 reversed-phase semi-preparative column. According to this method and to bioassays based on washed rabbit platelet aggregation, two lipid molecules with PAF-like activity and same retention times as those of standard PAF were detected; electron-spray ionization MS and MS/MS analysis revealed that they share similar structure with 16:0 and 18:0 PAF. Furthermore, other lipids extracted from Z. mobilis were found to exhibit a potent anti-PAF activity. Enzyme activities indicative of key PAF biosynthetic enzymes, such as dithiothreitol-insensitive cholinephosphotransferase (PAF-CPT) and lyso-PAF acetyltransferase were detected in Z. mobilis homogenates. As for PAF degradation, activity similar to that of PAF acetylhydrolase was also discovered. Overall, the presence of PAF, PAF-specific inhibitors, and enzyme activities relating to PAF metabolism, suggests that PAF may play an intrinsic role in this biotechnological organism. Practical applications:Z. mobilis is a platform microorganism for bioethanol production and a potential source of high-value chemicals of interest to the food and healthcare industries. Further investigation of PAF's role is bound to affect applications involving this and other biotechnological organisms. The finding that Z. mobilis lipids exhibit potent anti-PAF activity opens up prospects for their identification, overproduction and pharmaceutical use. The presented HPLC method for lipid fractionation accomplishes a one-step separation of lipids from dense samples, which may be successfully employed to other lipid-rich sources such as blood.

[1]  Gwo-Liang Chen,et al.  Improved genome annotation for Zymomonas mobilis , 2009, Nature Biotechnology.

[2]  A. Tsoupras,et al.  The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. , 2009, Infectious disorders drug targets.

[3]  M. Lazanas,et al.  Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? , 2008, AIDS research and human retroviruses.

[4]  T. Nomikos,et al.  Characterization of the De Novo Biosynthetic Enzyme of Platelet Activating Factor, DDT-Insensitive Cholinephosphotransferase, of Human Mesangial Cells , 2007, Mediators of inflammation.

[5]  Takao Shimizu,et al.  A Single Enzyme Catalyzes Both Platelet-activating Factor Production and Membrane Biogenesis of Inflammatory Cells , 2007, Journal of Biological Chemistry.

[6]  G. Panayotou,et al.  Isolation and identification of hydroxyl-platelet-activating factor from natural sources. , 2006, Life sciences.

[7]  Smaragdi Antonopoulou,et al.  Platelet activating factor — a molecular link between atherosclerosis theories , 2003 .

[8]  T. W. Jeffries,et al.  Bacteria engineered for fuel ethanol production: current status , 2003, Applied Microbiology and Biotechnology.

[9]  G. Baltas,et al.  Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. , 2003, Mediators of inflammation.

[10]  G. Zimmerman,et al.  Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological Processes , 2003, Critical reviews in clinical laboratory sciences.

[11]  J. López-Novoa Potential role of platelet activating factor in acute renal failure. , 1999, Kidney international.

[12]  Kulikov Vi,et al.  Ether lipids and platelet-activating factor: evolution and cellular function. , 1997 .

[13]  F. Snyder,et al.  CDP-choline:alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor. , 1997, Biochimica et biophysica acta.

[14]  N. Andrikopoulos,et al.  Lipid Separation from Urtica dioica: Existence of Platelet-Activating Factor , 1996 .

[15]  T. Tanaka,et al.  Platelet-activating factor and its structural analogues in the earthworm Eisenia foetida. , 1995, Biochimica et biophysica acta.

[16]  C. Iatrou,et al.  Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney. , 1994, The International journal of biochemistry.

[17]  H. Kumagai,et al.  Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells. , 1994, Biochimica et biophysica acta.

[18]  L. McManus,et al.  PAF molecular heterogeneity: pathobiological implications. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[19]  Yongxiang Wang,et al.  Recent cardiovascular drugs from Chinese medicinal plants. , 1993, Cardiovascular research.

[20]  S. Bozzaro,et al.  Dictyostelium cells produce platelet-activating factor in response to cAMP. , 1991, European journal of biochemistry.

[21]  I. Sobhani,et al.  Paf-acether synthesis by Helicobacter pylori. , 1990, Gut.

[22]  R. Lumb,et al.  Synthesis of platelet activating factor by tissues from the rainbow trout, Salmo gairdneri. , 1989, Biochimica et biophysica acta.

[23]  E. Dassa,et al.  Paf-acether production by Escherichia coli. , 1989, Biochemical and biophysical research communications.

[24]  L. Touqui,et al.  Perspectives in platelet-activating factor research. , 1987, Pharmacological reviews.

[25]  D. Stafforini,et al.  Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. , 1987, The Journal of biological chemistry.

[26]  M. Lekka,et al.  1‐O‐Alkyl‐2‐acetyl‐sn‐glyceryl‐3‐phosphorylcholine (PAF) is a minor lipid component in Tetrahymena pyriformis cells , 1986 .

[27]  C. Drainas,et al.  Growth requirements and the establishment of a chemically defined minimal medium inZymomonasmobilis , 1985, Biotechnology Letters.

[28]  L. Ingram,et al.  Lipid composition of Zymomonas mobilis: effects of ethanol and glucose , 1983, Journal of bacteriology.

[29]  D. Hanahan,et al.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.

[30]  J Swings,et al.  The biology of Zymomonas , 1977, Bacteriological reviews.

[31]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[32]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[33]  B. Rogala,et al.  Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. , 2008, Recent patents on inflammation & allergy drug discovery.

[34]  P. Rogers,et al.  Zymomonas mobilis for fuel ethanol and higher value products. , 2007, Advances in biochemical engineering/biotechnology.

[35]  M. Lazanas,et al.  PAF of biological fluids in disease: I.V. Levels in blood in allergic reactions induced by drugs , 2004, Archives of Dermatological Research.

[36]  R. N. Pinckard,et al.  PAF, a putative mediator of oral inflammation. , 2000, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[37]  Paramasamy Gunasekaran,et al.  Ethanol fermentation technology - Zymomonas mobilis. , 1999 .

[38]  H. Kumagai,et al.  Physiological action of PAF in yeast Saccharomyces cerevisiae. , 1996, Advances in experimental medicine and biology.

[39]  C. A. Demopoulos,et al.  A discovery trip to compounds with PAF-like activity. , 1996, Advances in experimental medicine and biology.

[40]  C. Drainas,et al.  Genetics and genetic engineering ofZymomonas mobilis , 1993, World journal of microbiology & biotechnology.